Nanotech Systems Inc.
Nanotech Systems Inc.: Initiative
Nanotech Systems Inc. / Key word(s): Miscellaneous
SEATTLE, WA, April 18, 2011- Nanotech Systems Inc. announced today that the company is launching a major initiative to investigate nanoparticle drug delivery of antibiotic compounds using PLGA of ( poly-lactide-co-glycolide), a nanomolecule with FDA approval for use in humans. Nanotech Systems CEO, Dr. David Scratchley, says that PLGA has been found useful for delivery of a host of different drugs but the use of PLGA to deliver antibiotics may lessen bacterial resistance to a wide spectrum of antibiotics ranging from American Bioanalytical's Gentamycin to Cefoxitin from Merck & Company. Dr. Scratchley believes that this area of study represents an effective strategy to expand Nanotech Systems' market for PLGA. Nanotech Systems is evaluating applications of PLGA as a means of delivering antibiotics to infections which may develop in the central nervous system as treatment of these infections is often difficult due to the problems encountered by antibiotics in crossing into the brain across the blood-brain barrier. Nanotech Systems ,Inc. (FWB: N95) is a materials science company developing unique and proprietary processes for delivery of pharmaceutical products intra body with reactive qualities and efficiencies to affect the diseased or compromised cells. Nanotech uses its broad intellectual property rights and proprietary know-how to establish application trials and testing for commercial application at both the academic and corporate level with programs throughout the U.S. and Canada and expansion into Europe. For more information, please visit www.nano-techgroup.com. This press release is for informational purposes only and does not constitute, or form part of an offer to buy of the solicitation of any offer to sell any securities in any jurisdiction not shall it (or any part of it), or the fact of its distribution, form the basis of or be relied on in connection with any contract therefore. End of Corporate News 18.04.2011 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de |
120533 18.04.2011 |